Prodrugs as new therapies against Chagas disease: in vivo synergy between Trypanosoma cruzi proline racemase inhibitors and benznidazole-Reference-Cited by-同舟云学术

Prodrugs as new therapies against Chagas disease: in vivo synergy between Trypanosoma cruzi proline racemase inhibitors and benznidazole

Published:2022-03 Issue: Volume:28 Page:84-89
ISSN:2213-7165
Container-title:Journal of Global Antimicrobial Resistance
language:en
Short-container-title:Journal of Global Antimicrobial Resistance

Author:

de Melo Guilherme Dias^ORCID,Coatnoan Nicolas,Gouault Nicolas,Cupif Jean-François,Renault Jacques,Cosson Alain,Uriac Philippe,Blondel Arnaud^ORCID,Minoprio Paola^ORCID

Publisher

Elsevier BV

Subject

Microbiology (medical),Immunology,Immunology and Allergy,Microbiology

Reference20 articles.

1. Chagas disease in the United States: a public health approach;Bern;Clin Microbiol Rev,2019

2. Searching for drugs for Chagas disease, leishmaniasis and schistosomiasis: a review;Santos;Int J Antimicrob Agents,2020

3. Oral transmission of Trypanosoma cruzi, Brazilian Amazon;Santana;Emerg Infect Dis,2019

4. Invasion mechanisms among emerging food-borne protozoan parasites;Yoshida;Trends Parasitol,2011

5. Research priorities for Chagas disease, human African trypanosomiasis and leishmaniasis. Technical report series n°975,2012

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Organic solvent-free Benznidazole nanosuspension as an approach to a novel pediatric formulation for Chagas disease;2023-11-02

2. Development of Novel Drugs for the Treatment of Chagas Disease;Current Topics in Zoonoses [Working Title];2023-09-10

3. Covalent Inhibitors for Neglected Diseases: An Exploration of Novel Therapeutic Options;Pharmaceuticals;2023-07-19

4. Bioactivity Screening and Chemical Characterization of Biocompound from Endophytic Neofusicoccum parvum and Buergenerula spartinae Isolated from Mangrove Ecosystem;Microorganisms;2023-06-16

5. Design and evaluation of substrate–product analog inhibitors for racemases and epimerases utilizing a 1,1-proton transfer mechanism;Methods in Enzymology;2023